Searched for
GLENMARK PHARMACEUTICALS FINANCIAL REPORT
Tax reporting lapses could risk India's sovereign rating, trigger withholding tax penalties: Income Tax Principal DG Debjyoti DasSpeaking to the media on the sidelines of the 'Summit on Global Financial Compliance (FATCA & CRS)' in Mumbai, Debjyoti Das, Principal Dire...- Glenmark Pharma Q2 Results: Net profit plunges 56% to Rs 264 crore, revenue down at Rs 4,247 crGlenmark Pharmaceuticals experienced a 56.78 percent drop in consolidated profit after tax during the September quarter. Total revenue from...
- Pills are paying off! Pharma stocks lead 2026 rally with up to 112% returnIn 2026, India's pharmaceutical stocks are making headlines with impressive year-to-date gains. This surge is driven by strong domestic dem...
- Bombay Coated & Special Steels shares to list today; GMP points to 10% listing premiumBombay Coated & Special Steels is set to list on November 5, 2026, with a 10% grey market premium following 63.89 times IPO subscription. T...
- Stocks in news: BSE, Lenskart, Nykaa, Bharti Airtel, LIC, Aurobindo Pharma and NalcoIndian equity markets have enjoyed a remarkable stretch, registering gains for five consecutive sessions. The Nifty 50 index showed impress...
- HRV Pharma buys Germany's PhateboThe acquisition marks virtual pharmaceutical company HRV's entry beyond active pharmaceutical ingredients (APIs) into finished formulations...
- Stop the price scam in our hospitalsA recent investigation in Maharashtra has shed light on concerning price hikes for medical supplies charged to patients. Items such as IV i...
- Emcure Pharma Q2 Results: Profit jumps 29% to Rs 325 croreEmcure Pharmaceuticals Ltd has posted a remarkable consolidated net profit of Rs 325.06 crore for the September quarter, reflecting substan...
- European shares fall as tech stocks slide, Middle East tensions weighEuropean shares declined as technology stocks led losses amid concerns over AI valuations and escalating US-Iran tensions. Rising oil price...
- Emcure Pharma shares jump 7% after Q2 profit rises 29% YoY to Rs 325 croreEmcure Pharmaceuticals shares rose up to 7.3% after the company reported a 29.3% year-on-year increase in Q2 FY27 profit to Rs 325.1 crore....
- Indian companies trust AI with greater autonomy but struggle to prove financial returns: ReportIndian companies are shifting towards AI-driven processes to enhance operational efficiency, but there's a catch. Despite the optimistic ou...
- Bayer raises 2026 profit outlook on strong pharmaceuticals performanceBayer raised its 2026 profit outlook after its pharmaceuticals division delivered stronger-than-expected third-quarter sales. The German gr...
- Hunting for Diwali winners? 8 brokerages name 58 stocks with big upside potential; Eternal, L&T among top picksEight brokerages have shortlisted 58 stocks for their Diwali 2026 portfolios across sectors such as banking, IT, defence, automobiles and h...
- Singapore's Grab lifts 2026 forecasts on strong ride-hailing, delivery demandSingapore's Grab lifted its annual forecasts on Tuesday, helped by steady growth in its ride-hailing unit, while demand for its delivery se...
- Jubilant Pharmova plans to raise Rs 800 crore via maiden bond issueJubilant Pharmova has announced plans to secure ₹800 crore via its first bond issuance within the local market, featuring ₹400 crore as the...
- Stocks in news: ITC, Marico, SBI, Yatra Online, NSE, Container Corp and Sun PharmaIndian equity benchmarks experienced gains, with Nifty nearing the 23,500 resistance level and strong corporate earnings reported. ITC face...
- Mold-Tek Packaging shares surge 17% as Q2 FY 27 profit jumps 35% YoY to Rs 21 croreMold-Tek Packaging shares surged nearly 17% after the company reported a 35.5% YoY rise in Q2 FY27 net profit and 30.5% revenue growth. Str...
- Spandana Sphoorty Financial reports cyberattack involving its bank accountSpandana Sphoorty Financial encountered a cyber fraud incident with unauthorized transactions on November 1. The amount involved was approx...
- Short-term headwinds, yes; owning the ecosystem is better: 20 healthcare stocks with downside risk of 23% to upside potential of 41%The healthcare sector is under scrutiny. The issue is pricing: What medicines cost and on what hospitals and the rest of the health ecosyst...
- Sun Pharma books Rs 346 crore Organon deal costs in Q2; profit falls 36%Sun Pharmaceutical Industries experienced a significant decline in net profit during the September quarter of FY27. The company incurred ac...
Load More
